Abcam to Acquire BioVision for $340 million
CAMBRIDGE, United Kingdom, Aug. 02, 2021 (GLOBE NEWSWIRE) — Abcam plc (AIM LSE: ABC; Nasdaq: ABCM) (“Abcam”, the Company or “the Group”), a global leader in the supply of life science research tools, today announces that it has entered into a definitive…
